Global Adult Dry Powder Inhalers Market Growth 2024-2030
Dry powder inhalers (DPIs) designed for adults are inhalation devices that deliver medication in a powdered form to the lungs for the treatment of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). These devices are optimized for adult use, considering factors such as ease of use, dose accuracy, portability, and effectiveness in drug delivery.
The global Adult Dry Powder Inhalers market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Adult Dry Powder Inhalers Industry Forecast” looks at past sales and reviews total world Adult Dry Powder Inhalers sales in 2023, providing a comprehensive analysis by region and market sector of projected Adult Dry Powder Inhalers sales for 2024 through 2030. With Adult Dry Powder Inhalers sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Adult Dry Powder Inhalers industry.
This Insight Report provides a comprehensive analysis of the global Adult Dry Powder Inhalers landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Adult Dry Powder Inhalers portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Adult Dry Powder Inhalers market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Adult Dry Powder Inhalers and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Adult Dry Powder Inhalers.
United States market for Adult Dry Powder Inhalers is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Adult Dry Powder Inhalers is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Adult Dry Powder Inhalers is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Adult Dry Powder Inhalers players cover GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Adult Dry Powder Inhalers market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Single Dose
Multi Dose
Segmentation by Application:
Asthma
COPD
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
3M
Hovione
Mannkind
Mylan
Novartis
Schering/Merck
Teva
Vectura
Key Questions Addressed in this Report
What is the 10-year outlook for the global Adult Dry Powder Inhalers market?
What factors are driving Adult Dry Powder Inhalers market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Adult Dry Powder Inhalers market opportunities vary by end market size?
How does Adult Dry Powder Inhalers break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.